MD Anderson Cancer Center: Combination Biomarker Predicts Response to Immune Checkpoint Therapy in Patients With Advanced Bladder Cancer

  • Shalini Singh Yadav

Press/Media

Period18 Jun 2020

Media coverage

1

Media coverage

  • TitleMD Anderson Cancer Center: Combination Biomarker Predicts Response to Immune Checkpoint Therapy in Patients With Advanced Bladder Cancer
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date18/06/20
    PersonsShalini Singh Yadav
View all 1
View less